Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Edelstein

Showing results (381-390 of 420) with videos related to

Pageof 42
Sort By:
Diabetes Care|June 16, 2021
Hyperglucagonemia Does Not Explain the β-Cell Hyperresponsiveness and Insulin Resistance in Dysglycemic Youth Compared With Adults: Lessons From the RISE StudySteven E Kahn, Kieren J Mather, Silva A Arslanian, et al.
BMC Nephrology|July 8, 2017
Urinalysis findings and urinary kidney injury biomarker concentrationsGirish N Nadkarni, Steven G Coca, Allison Meisner, et al.
Frontiers in Immunology|May 13, 2021
Islet Autoimmunity in Adults With Impaired Glucose Tolerance and Recently Diagnosed, Treatment Naïve Type 2 Diabetes in the Restoring Insulin SEcretion (RISE) StudyBarbara M Brooks-Worrell, Ashley H Tjaden, Sharon L Edelstein, et al.
Diabetes Care|June 17, 2021
Effect of Medical and Surgical Interventions on α-Cell Function in Dysglycemic Youth and Adults in the RISE StudySteven E Kahn, Sharon L Edelstein, Silva A Arslanian, et al.
Diabetes Care|October 13, 2017
Impact of Lifestyle and Metformin Interventions on the Risk of Progression to Diabetes and Regression to Normal Glucose Regulation in Overweight or Obese People With Impaired Glucose RegulationWilliam H Herman, Qing Pan, Sharon L Edelstein, et al.
Diabetes|April 1, 1997
Predictors of progression from impaired glucose tolerance to NIDDM: an analysis of six prospective studiesS L Edelstein, W C Knowler, R P Bain, et al.
Chemical Biology & Drug Design|December 4, 2009
Synthesis, properties, and applications of diazotrifluropropanoyl-containing photoactive analogs of farnesyl diphosphate containing modified linkages for enhanced stabilityMarisa L Hovlid, Rebecca L Edelstein, Olivier Henry, et al.
Journal of Community Health|August 12, 2021
Survey of Adherence with COVID-19 Prevention Behaviors During the 2020 Thanksgiving and Winter Holidays Among Members of the COVID-19 Community Research PartnershipJames E Peacock, David M Herrington, Sharon L Edelstein, et al.
Frontiers in Public Health|January 2, 2025
Long-term impact of Diabetes Prevention Program interventions on walking enduranceMedha N Munshi, Elizabeth M Venditti, Ashley H Tjaden, et al.
Diabetologia|August 4, 2017
Metformin for diabetes prevention: insights gained from the Diabetes Prevention Program/Diabetes Prevention Program Outcomes StudyVanita R Aroda, William C Knowler, Jill P Crandall, et al.
Pageof 42

Showing results (381-390 of 420) with videos related to

Sort By:
Pageof 42
Diabetes Care|June 16, 2021
Hyperglucagonemia Does Not Explain the β-Cell Hyperresponsiveness and Insulin Resistance in Dysglycemic Youth Compared With Adults: Lessons From the RISE StudySteven E Kahn, Kieren J Mather, Silva A Arslanian, et al.
BMC Nephrology|July 8, 2017
Urinalysis findings and urinary kidney injury biomarker concentrationsGirish N Nadkarni, Steven G Coca, Allison Meisner, et al.
Frontiers in Immunology|May 13, 2021
Islet Autoimmunity in Adults With Impaired Glucose Tolerance and Recently Diagnosed, Treatment Naïve Type 2 Diabetes in the Restoring Insulin SEcretion (RISE) StudyBarbara M Brooks-Worrell, Ashley H Tjaden, Sharon L Edelstein, et al.
Diabetes Care|June 17, 2021
Effect of Medical and Surgical Interventions on α-Cell Function in Dysglycemic Youth and Adults in the RISE StudySteven E Kahn, Sharon L Edelstein, Silva A Arslanian, et al.
Diabetes Care|October 13, 2017
Impact of Lifestyle and Metformin Interventions on the Risk of Progression to Diabetes and Regression to Normal Glucose Regulation in Overweight or Obese People With Impaired Glucose RegulationWilliam H Herman, Qing Pan, Sharon L Edelstein, et al.
Diabetes|April 1, 1997
Predictors of progression from impaired glucose tolerance to NIDDM: an analysis of six prospective studiesS L Edelstein, W C Knowler, R P Bain, et al.
Chemical Biology & Drug Design|December 4, 2009
Synthesis, properties, and applications of diazotrifluropropanoyl-containing photoactive analogs of farnesyl diphosphate containing modified linkages for enhanced stabilityMarisa L Hovlid, Rebecca L Edelstein, Olivier Henry, et al.
Journal of Community Health|August 12, 2021
Survey of Adherence with COVID-19 Prevention Behaviors During the 2020 Thanksgiving and Winter Holidays Among Members of the COVID-19 Community Research PartnershipJames E Peacock, David M Herrington, Sharon L Edelstein, et al.
Frontiers in Public Health|January 2, 2025
Long-term impact of Diabetes Prevention Program interventions on walking enduranceMedha N Munshi, Elizabeth M Venditti, Ashley H Tjaden, et al.
Diabetologia|August 4, 2017
Metformin for diabetes prevention: insights gained from the Diabetes Prevention Program/Diabetes Prevention Program Outcomes StudyVanita R Aroda, William C Knowler, Jill P Crandall, et al.
Pageof 42